Rupert Vessey

2.2k total citations
20 papers, 1.5k citations indexed

About

Rupert Vessey is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Rupert Vessey has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Rupert Vessey's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Asthma and respiratory diseases (6 papers) and Herpesvirus Infections and Treatments (5 papers). Rupert Vessey is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Asthma and respiratory diseases (6 papers) and Herpesvirus Infections and Treatments (5 papers). Rupert Vessey collaborates with scholars based in United States, United Kingdom and Netherlands. Rupert Vessey's co-authors include John A. Bilello, Wayomi R. Perera, Tom Wilkinson, Gerry Hagan, Jadwiga A. Wedzicha, Gavin C. Donaldson, John R. Hurst, Lynda Tussey, Awen Gallimore and John Toso and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Infectious Diseases and European Respiratory Journal.

In The Last Decade

Rupert Vessey

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupert Vessey United States 17 635 428 416 312 185 20 1.5k
Lokesh Guglani United States 17 581 0.9× 269 0.6× 413 1.0× 119 0.4× 153 0.8× 56 1.3k
Wan C. Tsai United States 19 378 0.6× 518 1.2× 797 1.9× 263 0.8× 231 1.2× 24 1.6k
Shean Aujla United States 10 495 0.8× 318 0.7× 1.2k 3.0× 653 2.1× 198 1.1× 15 2.2k
Louise Jones United Kingdom 17 129 0.2× 299 0.7× 585 1.4× 215 0.7× 86 0.5× 31 1.4k
Örjan Strannegård Sweden 23 139 0.2× 407 1.0× 409 1.0× 289 0.9× 104 0.6× 54 1.5k
Sowsan Atabani United Kingdom 18 210 0.3× 544 1.3× 656 1.6× 67 0.2× 264 1.4× 36 1.5k
C. Langston United States 18 775 1.2× 210 0.5× 239 0.6× 81 0.3× 124 0.7× 33 1.6k
John R. Greenland United States 24 399 0.6× 284 0.7× 365 0.9× 125 0.4× 237 1.3× 99 1.6k
M. Denis France 23 155 0.2× 467 1.1× 363 0.9× 96 0.3× 255 1.4× 65 1.3k
Peter Bundesen Australia 20 433 0.7× 219 0.5× 91 0.2× 95 0.3× 257 1.4× 46 1.7k

Countries citing papers authored by Rupert Vessey

Since Specialization
Citations

This map shows the geographic impact of Rupert Vessey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Vessey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Vessey more than expected).

Fields of papers citing papers by Rupert Vessey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupert Vessey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Vessey. The network helps show where Rupert Vessey may publish in the future.

Co-authorship network of co-authors of Rupert Vessey

This figure shows the co-authorship network connecting the top 25 collaborators of Rupert Vessey. A scholar is included among the top collaborators of Rupert Vessey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupert Vessey. Rupert Vessey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto-Plata, Víctor, John Toso, Kwan Lee, et al.. (2012). Use of Proteomic Patterns of Serum Biomarkers in Patients with Chronic Obstructive Pulmonary Disease.
2.
Lange, Joep M. A., Stephen K. Tyring, Gregory A. Poland, et al.. (2011). Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vaccine. 30(5). 904–910. 50 indexed citations
3.
Weinberg, Adriana, Ann Lazar, Gary O. Zerbe, et al.. (2010). Influence of Age and Nature of Primary Infection on Varicella‐Zoster Virus–Specific Cell‐Mediated Immune Responses. The Journal of Infectious Diseases. 201(7). 1024–1030. 95 indexed citations
4.
Loboda, Andrey, Michael Nebozhyn, Chi‐Fung Cheng, et al.. (2009). Biomarker Discovery: Identification of a Growth Factor Gene Signature. Clinical Pharmacology & Therapeutics. 86(1). 92–96. 13 indexed citations
5.
Man, S. F. Paul, Xuekui Zhang, Rupert Vessey, et al.. (2009). The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Therapeutic Advances in Respiratory Disease. 3(2). 73–80. 20 indexed citations
6.
Man, S. F. Paul, Li Xing, John E. Connett, et al.. (2008). Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?. European Respiratory Journal. 32(6). 1451–1457. 48 indexed citations
7.
Pinto-Plata, Víctor, John Toso, Karen Lee, et al.. (2007). Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 62(7). 595–601. 164 indexed citations
8.
Levin, Myron J., et al.. (2007). Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine. Vaccine. 25(41). 7087–7093. 36 indexed citations
9.
Pauwels, Romain, Guy Joos, Charles Fogarty, et al.. (2007). Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD. Pulmonary Pharmacology & Therapeutics. 21(2). 385–392.
10.
Hurst, John R., Gavin C. Donaldson, Wayomi R. Perera, et al.. (2006). Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 174(8). 867–874. 344 indexed citations
11.
12.
Singh, Dave, Ruth Tal‐Singer, Isidore Faiferman, et al.. (2006). Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double‐blind, placebo‐controlled, cross‐over study in healthy subjects. British Journal of Clinical Pharmacology. 61(4). 398–404. 16 indexed citations
13.
Pinto-Plata, Víctor, Hana Müllerová, John Toso, et al.. (2006). C-reactive protein in patients with COPD, control smokers and non-smokers. 1(3). 102–102. 77 indexed citations
14.
Holz, Olaf, Ruth Tal‐Singer, Frank Kanniess, et al.. (2005). Validation of the Human Ozone Challenge Model as a Tool for Assessing Anti‐Inflammatory Drugs in Early Development. The Journal of Clinical Pharmacology. 45(5). 498–503. 33 indexed citations
15.
Smith, Jeffrey G., Myron J. Levin, Rupert Vessey, et al.. (2003). Measurement of cell-mediated immunity with a varicella-zoster virus-specific interferon-? ELISPOT assay: Responses in an elderly population receiving a booster immunization. Journal of Medical Virology. 70(S1). S38–S41. 39 indexed citations
16.
Tussey, Lynda, Bradley H. Edwards, Karen M. Grimm, et al.. (2003). Antigen Burden Is a Major Determinant of Human Immunodeficiency Virus–Specific CD8+T Cell Maturation State: Potential Implications for Therapeutic Immunization. The Journal of Infectious Diseases. 187(3). 364–374. 52 indexed citations
17.
Chan, Ivan S. F., Shu Li, Holly Matthews, et al.. (2002). Use of statistical models for evaluating antibody response as a correlate of protection against varicella. Statistics in Medicine. 21(22). 3411–3430. 39 indexed citations
18.
Tussey, Lynda, et al.. (2000). Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. European Journal of Immunology. 30(7). 1823–1829. 80 indexed citations
19.
20.
Fuller, Deborah H., Mei‐Li Wu, James T. Fuller, et al.. (2000). Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B.. PubMed. 104. 115–9. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lokesh Guglani Breakdown of academic impact, for papers by Wan C. Tsai Breakdown of academic impact, for papers by Shean Aujla Breakdown of academic impact, for papers by Louise Jones Breakdown of academic impact, for papers by Örjan Strannegård Breakdown of academic impact, for papers by Sowsan Atabani Breakdown of academic impact, for papers by C. Langston Breakdown of academic impact, for papers by John R. Greenland Breakdown of academic impact, for papers by M. Denis Breakdown of academic impact, for papers by Peter Bundesen
Rankless by CCL
2026